Apeiron Synthesis
Michal Bieniek is the CEO of Apeiron Synthesis, a fine chemical company based in Poland that has been operational since 2009 and specializes in the development of innovative metathesis catalysts. Prior to this role, Michal served as a Research Scientist at Uniwersytet Warszawski in early 2009 and completed a trainee position at Evonik in late 2006. Michal holds a Doctor of Philosophy (PhD) in Organic Chemistry from the Polish Academy of Sciences, earned between 2004 and 2008, and a Master of Science Engineering (M.Sc. Eng.) in the Technology of Biologically Active Compounds and Cosmetics from Warsaw University of Technology, completed in 2003.
This person is not in any teams
This person is not in any offices
Apeiron Synthesis
The mission of Apeiron Synthesis is to fully realize the potential of olefin metathesis in synthetic chemistry, with efficient and cost-effective solutions for R&D and commercial manufacturing processes – solutions that can benefit a wide range of industries, including agrichemicals, fine chemicals, flavor and fragrances, polymers and Pharma/Biopharma. Catalytic olefin metathesis technology offers chemists remarkable efficiency over traditional methods for building complex molecules - fewer synthetic steps and byproducts, reduced waste, and higher reaction concentrations - significantly lowering costs. Apeiron has developed a growing portfolio of over twenty high performance metathesis catalysts, available in milligram to multi-kilogram quantities, designed to accommodate a wide range of applications. With an uncompromising commitment to the design and use of robust new catalysts, our team of specialists is available to help customers transform their chemistry with metathesis technology. Olefin metathesis was discovered in the 1950’s as “olefin disproportionation”, with primarily industrial applications using harsh conditions. The first generations of homogeneous metathesis catalyses enabled transformations using relatively mild reaction conditions, with the potential to revolutionize the way chemists synthesize organic molecules – recognized as such with the 2005 Nobel Prize for Chemistry awarded to pioneers in the field. Apeiron is leading the way to diverse new applications to transform catalytic olefin metathesis from a technology with high potential to an important part of every chemist’s toolkit.